REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 89 filers reported holding REGULUS THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $66,000 | -88.5% | 40,000 | -84.4% | 0.00% | -87.5% |
| Q4 2016 | $576,000 | -31.8% | 255,800 | 0.0% | 0.01% | -38.5% |
| Q3 2016 | $844,000 | +93.6% | 255,800 | +411.6% | 0.01% | +62.5% |
| Q4 2015 | $436,000 | +33.3% | 50,000 | 0.0% | 0.01% | +14.3% |
| Q3 2015 | $327,000 | -40.3% | 50,000 | 0.0% | 0.01% | -36.4% |
| Q2 2015 | $548,000 | -35.3% | 50,000 | 0.0% | 0.01% | -35.3% |
| Q1 2015 | $847,000 | +5.6% | 50,000 | 0.0% | 0.02% | -5.6% |
| Q4 2014 | $802,000 | – | 50,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |